Multicomponent Intervention to Improve Hypertension Control in Central America
Implementing a Multicomponent Intervention to Improve Hypertension Control in Central America
1 other identifier
interventional
1,854
1 country
1
Brief Summary
The investigators propose to assess the needs, barriers, and knowledge gaps of hypertension control programs in the national health care systems of the Central America 4 region LMIC (CA-4: Guatemala, Honduras, El Salvador, and Nicaragua); to conduct a cluster randomized trial to test the effect of a multilevel and multicomponent intervention program leveraging an existing subnational primary healthcare system in Guatemala, on blood pressure (BP) control among hypertensive patients; and to evaluate the adaptability, feasibility, fidelity, and sustainability of implementing the program in the primary health care systems of the CA-4 region. The comprehensive intervention, which includes protocol-based treatment using a standard BP management algorithm, team-based collaborative care, BP audit and feedback, home BP monitoring, and health coaching on antihypertensive medication adherence and lifestyle modification, will last for 18 months. This implementation research study presents high public health impact because it will generate urgently needed data on effective, practical, and sustainable intervention strategies aimed at reducing BP related disease burden in Central America and other low- and middle-income countries.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for phase_3
Started Jul 2019
Typical duration for phase_3
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 12, 2018
CompletedFirst Posted
Study publicly available on registry
April 20, 2018
CompletedStudy Start
First participant enrolled
July 17, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 23, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
April 23, 2022
CompletedJuly 29, 2022
July 1, 2022
2.8 years
April 12, 2018
July 27, 2022
Conditions
Outcome Measures
Primary Outcomes (1)
Proportion of controlled blood pressure
Difference in the proportion of patients with controlled blood pressure (\<140/90 mmHg) between the intervention and control groups
18 months
Secondary Outcomes (2)
Change in systolic blood pressure
18 months
Change in diastolic blood pressure
18 months
Study Arms (2)
Intervention group
EXPERIMENTALPatients will receive a multicomponent intervention.
Control group
NO INTERVENTIONPatients will receive the usual care.
Interventions
An 18-month multicomponent intervention, which includes protocol-based treatment using: a standard blood pressure (BP) management algorithm, team-based collaborative care, BP audit and feedback, home BP monitoring, and health coaching on antihypertensive medication adherence and lifestyle modification.
Eligibility Criteria
You may qualify if:
- All patients aged ≥40 years with BP \>140/90 mmHg at the time of enrollment
- Patients who receive care at government health facilities
You may not qualify if:
- Pregnant women
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Institute of Nutrition of Central America and Panamalead
- Tulane University School of Public Health and Tropical Medicinecollaborator
- Institute for Clinical Effectiveness and Health Policycollaborator
- Colorado School of Public Healthcollaborator
- National Heart, Lung, and Blood Institute (NHLBI)collaborator
Study Sites (1)
Insitute of Nutrition of Central America and Panama
Guatemala City, 01011, Guatemala
Related Publications (3)
Paniagua-Avila A, Shelton RC, Figueroa JC, Guzman AL, Gutierrez L, Hernandez-Galdamez DR, Ramirez JM, Rodriguez J, Irazola V, Ramirez-Zea M, Fort MP. Assessing the implementation of a multi-component hypertension program in a Guatemalan under-resourced dynamic context: an application of the RE-AIM/PRISM extension for sustainability and health equity. Implement Sci Commun. 2024 Mar 15;5(1):23. doi: 10.1186/s43058-024-00560-5.
PMID: 38491376DERIVEDPaniagua-Avila A, Shelton RC, Guzman AL, Gutierrez L, Galdamez DH, Ramirez JM, Rodriguez J, Irazola V, Ramirez-Zea M, Fort MP. Assessing the implementation of a multi-component hypertension program in a Guatemalan under-resourced dynamic context: An application of the RE-AIM/PRISM extension for sustainability and health equity. Res Sq [Preprint]. 2023 Jan 17:rs.3.rs-2362741. doi: 10.21203/rs.3.rs-2362741/v1.
PMID: 36712105DERIVEDPaniagua-Avila A, Fort MP, Glasgow RE, Gulayin P, Hernandez-Galdamez D, Mansilla K, Palacios E, Peralta AL, Roche D, Rubinstein A, He J, Ramirez-Zea M, Irazola V. Evaluating a multicomponent program to improve hypertension control in Guatemala: study protocol for an effectiveness-implementation cluster randomized trial. Trials. 2020 Jun 9;21(1):509. doi: 10.1186/s13063-020-04345-8.
PMID: 32517806DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- phase 3
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Head, INCAP Research Center for the Prevention of Chronic Diseases
Study Record Dates
First Submitted
April 12, 2018
First Posted
April 20, 2018
Study Start
July 17, 2019
Primary Completion
April 23, 2022
Study Completion
April 23, 2022
Last Updated
July 29, 2022
Record last verified: 2022-07